These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 119908)

  • 1. [Mild hypertension: drug prophylaxis or primary prevention?].
    Borgers D
    MMW Munch Med Wochenschr; 1979 Oct; 121(43):1407-10. PubMed ID: 119908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Necessary prevention of the complications of hypertension (II)].
    Froment A; Milon H; Froment R
    Nouv Presse Med; 1975 Jun; (23):1745-6, 1748-50. PubMed ID: 1161467
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension.
    Koul S
    Nurs J India; 2007 Mar; 98(3):55-7. PubMed ID: 18236654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of outpatient polyclinic institutions in providing the mass prophylaxis of cardiovascular diseases].
    Oganov RG; Glazunov IS
    Ter Arkh; 1985; 57(1):6-9. PubMed ID: 3983847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary prevention and screening in adults: update 2006].
    Cornuz J; Guessous I; Rodondi N
    Rev Med Suisse; 2006 Jan; 2(50):262-73. PubMed ID: 16503042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factor profiles in mild to moderate hypertensives seen at Kenyatta National Hospital.
    Yonga GO; Ogola EN; Juma FD
    East Afr Med J; 1993 Nov; 70(11):693-5. PubMed ID: 8033770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New indications for the prevention of cardiovascular diseases].
    Tenconi MT;
    Ann Ig; 2008; 20(3 Suppl 1):53-7. PubMed ID: 18773606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychological characteristics of patients with borderline arterial hypertension and prophylaxis of cardiovascular diseases].
    Zaĭtsev VP; Dvortsov SA
    Sov Med; 1991; (5):50-2. PubMed ID: 1876924
    [No Abstract]   [Full Text] [Related]  

  • 10. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategy for the mass prevention of the main cardiovascular diseases in adults].
    Epstein FH
    Ter Arkh; 1985; 57(11):13-20. PubMed ID: 4082011
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension management in primary care: standard care and attitude towards a disease management model.
    Wassenberg MW; Willemsen JM; Gaillard CA; Braam B
    Neth J Med; 2004 Nov; 62(10):375-82. PubMed ID: 15683092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart protection: controlling risk factors for cardiovascular disease.
    Pennington JC; Tecce MA; Segal BL
    Geriatrics; 1997 Dec; 52(12):40-2,45,49-50; quiz 51. PubMed ID: 9413251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cardiovascular screening in primary care worthwhile?
    Coope JR
    J Hum Hypertens; 1995 Oct; 9(10):785-6. PubMed ID: 8576891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of hypertension in the community. An Israeli experience].
    Viskoper RJ; Silverberg DS; Hermoni Y; Eyal P
    Rev Clin Esp; 1986 May; 178(9):459-61. PubMed ID: 3738034
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 19. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-economic aspects of screening and prevention of arterial hypertension and arteriosclerosis.
    Holland WW
    Acta Cardiol Suppl; 1988; 29():151-4. PubMed ID: 3389025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.